<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="first line intervention for glucose transporter 1 deficiency syndrome and" exact="pyruvate dehydrogenase deficiency," post="and is recommended for refractory epilepsy. It is a"/>
 <result pre="into account their metabolic and health effects. ketogenic diet food" exact="epilepsy" post="glucose transporter 1 deficiency syndrome pyruvate dehydrogenase deficiency children"/>
 <result pre="effects. ketogenic diet food epilepsy glucose transporter 1 deficiency syndrome" exact="pyruvate dehydrogenase deficiency" post="children adult 1. Introduction The ketogenic diet (KD) is"/>
 <result pre="international guidelines, is recommended for children and adults with drug-refractory" exact="epilepsy" post="and two rare neurometabolic disorders: glucose transporter 1 deficiency"/>
 <result pre="with developmental delay and other neurological problems, including a complex" exact="movement disorder." post="The use of ketone bodies as an alternative fuel"/>
 <result pre="disease, migraine/headache, depression, glycogenosis, high grade glioblastoma [ 28], and" exact="amyotrophic lateral sclerosis," post="as well as for metabolic and endocrine disorders like"/>
 <result pre="well as for metabolic and endocrine disorders like diabetes, obesity," exact="metabolic syndrome," post="poly-cystic ovary syndrome, and congenital hyperinsulinism [ 29, 30,"/>
 <result pre="deficiencies, growth retardation, and hyperlipidemia. Gastrointestinal side effects include constipation," exact="diarrhea" post="(particularly in patients with MCT supplementation), nausea, vomiting and,"/>
 <result pre="[ 71]. Another prospective study treated 121 children with intractable" exact="epilepsy" post="with olive oil-based KDs (the olive oil amount was"/>
 <result pre="association between nuts consumption and the risk of hyperlipidemia and" exact="cardiovascular disease" post="[ 75]. However, the effects of nuts in subjects"/>
 <result pre="reason, such products are widely used in the treatment of" exact="obesity" post="and by diabetic subjects. Instead, the use of sweeteners"/>
 <result pre="single doses ranging from 10–30 g are normally tolerated without" exact="diarrhea" post="[ 91]. In this light, small amounts of xylitol,"/>
 <result pre="of 40 g, more than of 50% of subjects developed" exact="diarrhea" post="[ 93]. Sorbitol, a polyol naturally found in some"/>
 <result pre="can lead to more distressing symptoms, like abdominal pain and" exact="diarrhea" post="[ 99, 100]. Maltitol is a disaccharide polyol, consisting"/>
 <result pre="intestine, it can pull water into the gut causing osmotic" exact="diarrhea" post="[ 91]. Moreover, given the intense production of gases,"/>
 <result pre="are the glucomannan-based products developed for the dietary treatment of" exact="obesity" post="and for losing weight, and also these are used"/>
 <result pre="intractable childhood epilepsy. In this study, 30 children with intractable" exact="epilepsy" post="were prospectively followed for two months. During the first"/>
 <result pre="double-blind, placebo-controlled randomized trial did not find any amelioration of" exact="constipation" post="in children treated with glucomannan compared to the children"/>
 <result pre="this is in order to reduce the risk of future" exact="dyslipidemia" post="and cardiovascular problems. Moreover, given the reduced consumption of"/>
 <result pre="29881797 2. Cervenka M.C. Kossoff E.H. Dietary treatment of intractable" exact="epilepsy" post="Continuum (Minneap Minn) 2013 19 756 766 10.1212/01.CON.0000431396.23852.56 23739109"/>
 <result pre="Damasceno N.R. Neurobiochemical mechanisms of a ketogenic diet in refractory" exact="epilepsy" post="Clinics (Sao Paulo) 2014 69 699 705 10.6061/clinics/2014(10)09 25518023"/>
 <result pre="Prasad C. Rupar T. Prasad A.N. Pyruvate dehydrogenase deficiency and" exact="epilepsy" post="Brain Dev. 2011 33 856 865 10.1016/j.braindev.2011.08.003 21908116 21."/>
 <result pre="Mukherjee P. Metabolic therapy: A new paradigm for managing malignant" exact="brain cancer" post="Cancer Lett. 2015 356 289 300 10.1016/j.canlet.2014.07.015 25069036 29."/>
 <result pre="P. Metabolic therapy: A new paradigm for managing malignant brain" exact="cancer" post="Cancer Lett. 2015 356 289 300 10.1016/j.canlet.2014.07.015 25069036 29."/>
 <result pre="of a very-low-carbohydrate ketogenic diet in adults with Type 1" exact="diabetes mellitus" post="may be opposed by increased hypoglycaemia risk and dyslipidaemia"/>
 <result pre="C. Curtis R. Schuller R. Growth retardation in children with" exact="epilepsy" post="on the ketogenic diet: A retrospective chart review J."/>
 <result pre="children on the ketogenic diet as a treatment for intractable" exact="epilepsy" post="J. Am. Diet. Assoc. 2005 105 718 725 10.1016/j.jada.2005.02.009"/>
 <result pre="on growth and resting energy expenditure in children with intractable" exact="epilepsy" post="Dev. Med. Child. Neurol. 2014 56 898 904 10.1111/dmcn.12462"/>
 <result pre="and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant" exact="epilepsy" post="and maintained on the ketogenic diet Clin. Nutr. 2019"/>
 <result pre="J.E. Pyzik P.L. Kossoff E.H. Management and risk factors for" exact="dyslipidemia" post="with the ketogenic diet J. Child. Neurol. 2008 23"/>
 <result pre="treatment on lipoprotein subfractions in children and adolescents with refractory" exact="epilepsy" post="Nutrition 2017 33 271 277 10.1016/j.nut.2016.06.016 27712963 55. Klein"/>
 <result pre="A. Weissberger R. Ketogenic diet treatment in adults with refractory" exact="epilepsy" post="Epilepsy Behav. 2010 19 575 579 10.1016/j.yebeh.2010.09.016 20937568 56."/>
 <result pre="Long-term use of the ketogenic diet in the treatment of" exact="epilepsy" post="Dev. Med. Child. Neurol. 2006 48 978 981 10.1017/S0012162206002143"/>
 <result pre="the modified Atkins diet on lipid profiles in adults with" exact="epilepsy" post="Nutr. Neurosci. 2016 19 131 137 10.1179/1476830514Y.0000000162 25383724 60."/>
 <result pre="A prospective study of the modified Atkins diet for intractable" exact="epilepsy" post="in adults Epilepsia 2008 49 316 319 10.1111/j.1528-1167.2007.01256.x 17919301"/>
 <result pre="Ketogenic Diet on serum selenium levels in patients with intractable" exact="epilepsy" post="Biol. Trace Elem. Res. 2017 178 1 6 10.1007/s12011-016-0897-7"/>
 <result pre="S. Jin Y. Lu J. Nut consumption and risk of" exact="metabolic syndrome" post="and overweight/obesity: A meta-analysis of prospective cohort studies and"/>
 <result pre="Med. 2018 10.1089/acm.2018.0212 77. Neal E.G. Ketogenic dietary therapy for" exact="epilepsy" post="and other disorders: Current perspectives Nutr. Diet. Suppl. 2014"/>
 <result pre="C. Bilotta T. Ricciardi M.R. Villotti G. Fallucca F. Sorbitol" exact="malabsorption" post="and nonspecific abdominal symptoms in type II diabetes Metabolism"/>
 <result pre="T. Suppressive effect of partially hydrolyzed guar gum on transitory" exact="diarrhea" post="induced by ingestion of maltitol and lactitol in healthy"/>
 <result pre="effect on blood lactate in healthy volunteers and patients with" exact="cirrhosis" post="Eur. J. Clin. Pharmacol. 1988 35 97 99 10.1007/BF00555516"/>
 <result pre="use of a formula-based ketogenic diet in children with refractory" exact="epilepsy" post="Arq. Neuropsiquiatr. 2017 75 234 237 10.1590/0004-282x20170028 28489143 121."/>
 <result pre="S.A. La Vega-Talbott M. Solomon G.E. Ketogenic diet in pediatric" exact="epilepsy" post="patients with gastrostomy feeding Pediatr. Neurol. 2005 32 81"/>
 <result pre="Metabolic and anticonvulsant effects of two ketogenic diets in childhood" exact="epilepsy" post="Pediatr. Res. 1976 10 536 540 10.1203/00006450-197605000-00006 934725 129."/>
 <result pre="X.Q. Zhao Z.J. Lv L.X. Effect of glucomannan on functional" exact="constipation" post="in children: A systematic review and meta-analysis of randomised"/>
 <result pre="Toraldo C. Effect of the dietary fiber glucomannan on chronic" exact="constipation" post="in neurologically impaired children J. Pediatr. 2000 136 41"/>
 <result pre="A. Fiber (glucomannan) is beneficial in the treatment of childhood" exact="constipation" post="Pediatrics 2004 113 e259 e264 10.1542/peds.113.3.e259 14993586 134. Passaretti"/>
 <result pre="H. Glucomannan is not effective for the treatment of functional" exact="constipation" post="in children: A double-blind, placebo-controlled, randomized trial Clin. Nutr."/>
 <result pre="ketone bodies production 10–30 g are generally well tolerated without" exact="diarrhea" post="Mannitol 25 75 25 50–70 1.6 - 10–20 g"/>
 <result pre="- 10–20 g have laxative effects. Higher doses can provoke" exact="diarrhea" post="Sorbitol 25 75 0 50–70 2.6 Decrement of the"/>
 <result pre="and flatulence. 20 g can lead to abdominal pain and" exact="diarrhea" post="Maltitol 45 55 0 75–90 2.1–2.4 Increment of blood"/>
 <result pre="to mild borborygmus and flatus. Higher doses can lead to" exact="diarrhea" post="Isomalt 10 90 0 65 2.0 - Over 40"/>
</results>
